MedPath

Clinical significance of salivary alpha-amylase activity in patients with Parkinson's disease

Not Applicable
Recruiting
Conditions
s desease
Parkinson&#39
Registration Number
JPRN-UMIN000041956
Lead Sponsor
Department of Clinical Research, Tokushima National Hospital National Hospital Organization
Brief Summary

There was no difference in salivary alpha-amylase(sAA) levels between the Parkinson's disease (PD) and control groups, while subjective stress in the control group was higher than in the PD group. On the other hand, subjective stress in the control group was higher than that in the PD group. sAA reflected mental stress in PD, but was highly related to age, not mental stress, in healthy subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
255
Inclusion Criteria

Not provided

Exclusion Criteria

Unwillingness to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath